ADRs End Higher; Adaptimmune Therapeutics PLC Climbs 52%

Dow Jones
Oct 09

This article was automatically generated by Dow Jones using technology from Automated Insights.

International stocks trading in New York closed higher on Wednesday, as the S&P/BNY Mellon index of American depositary receipts added 0.9% to 231.80.

The European index added 0.3% to 199.90. The Asian index increased 1.6% to 319.99. The Latin American index rose 1.1% to 212.47, while the emerging-markets index increased 1.9% to 533.52.

United Kingdom's Adaptimmune Therapeutics PLC was the biggest leader during the session, rocketing 52% to 21 cents, and Israel-based XTL Biopharmaceuticals Ltd. soared 52% to $2.13. Nanobiotix S.A., which is based in France, rounded out the top three leaders on Wednesday, with shares soaring 31% to $27.46.

Lixiang Education Holding Co. Ltd., based in China, posted the largest decline, tumbling 17% to 67 cents, followed by shares of United Kingdom's NuCana PLC, which tumbled 16% to $5.92. Shares of China-based YXT.COM Group Holding Ltd. dropped 7.2% to $1.03.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

October 08, 2025 16:30 ET (20:30 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10